In tumor cells, PTEN acts as an anti-proliferative agent by inhibiting cyclin D1 transcription through AKT inactivation and increasing lipid phosphatase activity in the cytoplasm, resulting in elevated p27 expression. Here, AKT1 is linked to neoplasm.